YEAMAN KEVIN J
SEC CIK 1200469 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DLB | Dolby Laboratories, Inc. | Pres, CEO, Dir | 98.4K | $200.06 | $71.88M | 78 | 2021-07-13 | 2025-12-16 |
Most active insiders at DLB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | YEAMAN KEVIN J | Pres, CEO, Dir | — | $8.72M |
| 2 | Couling John D | SVP, Entertainment | — | $3.82M |
| 3 | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | — | $1.08M |
| 4 | Revankar Shriram | SVP, Advanced Technology Group | — | $747.9K |
| 5 | Pendleton Todd | SVP, CMO | — | $647.9K |
| 6 | Nicholson Ryan | VP, CAO, Corp. Ctrl | — | $359.5K |
| 7 | Park Robert J | SVP, CFO | — | $277.4K |
| 8 | Prophet Tony A | Dir | — | $223.9K |
| 9 | Rollins Emily | Dir | — | $60.1K |
| 10 | Whitten Marc | Pres, CEO, Dir | — | — |
Transactions 78
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | A - Grant | $0.00 | +66.0K | 193.7K | +52% | $0 |
| DT | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | +17.6K | 202.6K | +10% | $0 |
| DMT | 2025-12-17 | 2025-12-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $67.35 | -34.0K | 143.8K | -19% | -$2.29M |
| DMTI | 2025-12-17 | 2025-12-16+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $66.84 | -33.5K | 98.4K | -25% | -$2.24M |
| DMTI | 2025-12-11 | 2025-12-09 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $51.40 | +34.4K | 132.7K | +35% | +$1.77M |
| DMTI | 2025-12-11 | 2025-12-09 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $67.08 | -34.4K | 98.4K | -26% | -$2.31M |
| DMTI | 2025-11-26 | 2025-11-24 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $51.59 | +36.7K | 151.4K | +32% | +$1.89M |
| DTI | 2025-11-26 | 2025-11-24 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $66.91 | -36.7K | 114.7K | -24% | -$2.46M |
| DTI | 2025-11-26 | 2025-11-26 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | G - Gift | $0.00 | -16.3K | 98.4K | -14% | $0 |
| DTI | 2025-10-16 | 2025-10-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +25.0K | 139.7K | +22% | +$1.14M |
| DMTI | 2025-10-16 | 2025-10-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $68.87 | -25.0K | 114.7K | -18% | -$1.72M |
| DTI | 2025-09-18 | 2025-09-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +25.0K | 139.7K | +22% | +$1.14M |
| DTI | 2025-09-18 | 2025-09-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $71.66 | -25.0K | 114.7K | -18% | -$1.79M |
| DTI | 2025-08-14 | 2025-08-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $72.31 | -25.0K | 114.7K | -18% | -$1.81M |
| DTI | 2025-08-14 | 2025-08-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +25.0K | 139.7K | +22% | +$1.14M |
| DMTI | 2025-07-17 | 2025-07-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $74.82 | -42.4K | 115.0K | -27% | -$3.17M |
| DMTI | 2025-07-17 | 2025-07-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $53.33 | +42.4K | 117.2K | +57% | +$2.26M |
| DTI | 2025-06-26 | 2025-06-24 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $74.02 | -25.0K | 114.7K | -18% | -$1.85M |
| DTI | 2025-06-26 | 2025-06-24 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +25.0K | 139.7K | +22% | +$1.14M |
| DMTI | 2025-06-12 | 2025-06-10 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $76.22 | -33.7K | 114.9K | -23% | -$2.57M |
| DMTI | 2025-06-12 | 2025-06-10 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $50.42 | +33.7K | 139.7K | +32% | +$1.70M |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | A - Grant | $0.00 | +54.4K | 174.7K | +45% | $0 |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $79.18 | -31.5K | 127.7K | -20% | -$2.49M |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | +15.5K | 182.5K | +9% | $0 |
| DMTI | 2024-11-27 | 2024-11-25+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $62.32 | +57.9K | 91.6K | +172% | +$3.61M |
| DMTI | 2024-11-27 | 2024-11-25+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $80.49 | -57.9K | 83.7K | -41% | -$4.66M |
| DTI | 2024-10-17 | 2024-10-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $62.32 | +28.5K | 112.2K | +34% | +$1.78M |
| DMTI | 2024-10-17 | 2024-10-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $74.12 | -28.5K | 83.7K | -25% | -$2.11M |
| I | 2024-06-25 | 2024-06-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | P - Purchase | $78.15 | +2.56 | 2.56 | New | +$200.06 |
| DI | 2024-01-19 | 2024-01-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $83.51 | -9,030 | 83.7K | -10% | -$754.1K |
| DMI | 2024-01-19 | 2024-01-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.43 | +9,030 | 92.8K | +11% | +$410.2K |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | A - Grant | $0.00 | +46.7K | 166.3K | +39% | $0 |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | — | +17.2K | 174.8K | +11% | — |
| DM | 2023-12-19 | 2023-12-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $88.41 | -31.3K | 120.3K | -21% | -$2.77M |
| DI | 2023-12-14 | 2023-12-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $89.17 | -18.1K | 51.9K | -26% | -$1.61M |
| DI | 2023-12-14 | 2023-12-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +18.1K | 69.9K | +35% | +$776.2K |
| DI | 2023-11-24 | 2023-11-21 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +45.1K | 97.0K | +87% | +$1.94M |
| DMI | 2023-11-24 | 2023-11-21 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $84.80 | -45.1K | 51.9K | -47% | -$3.83M |
| DMI | 2023-10-19 | 2023-10-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $82.33 | -9,030 | 51.9K | -15% | -$743.4K |
| DI | 2023-10-19 | 2023-10-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +9,030 | 60.9K | +17% | +$388.1K |
| DMI | 2023-09-14 | 2023-09-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $82.62 | -18.1K | 53.2K | -25% | -$1.49M |
| DI | 2023-09-14 | 2023-09-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +18.1K | 69.9K | +35% | +$776.2K |
| DMI | 2023-07-13 | 2023-07-11+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +45.1K | 79.0K | +134% | +$1.94M |
| DMI | 2023-07-13 | 2023-07-11+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $89.13 | -45.1K | 51.9K | -47% | -$4.02M |
| DI | 2023-06-15 | 2023-06-13 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $84.83 | -27.1K | 51.9K | -34% | -$2.30M |
| DI | 2023-06-15 | 2023-06-13 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +27.1K | 79.0K | +52% | +$1.16M |
| DI | 2023-05-18 | 2023-05-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $83.65 | -9,030 | 51.9K | -15% | -$755.4K |
| DI | 2023-05-18 | 2023-05-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +9,030 | 60.9K | +17% | +$388.1K |
| DI | 2023-04-13 | 2023-04-11 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $84.44 | -30.8K | 51.9K | -37% | -$2.60M |
| DI | 2023-04-13 | 2023-04-11 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +30.8K | 82.7K | +59% | +$1.40M |
| DMI | 2023-03-16 | 2023-03-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $81.11 | -30.8K | 51.9K | -37% | -$2.50M |
| DI | 2023-03-16 | 2023-03-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +30.8K | 82.7K | +59% | +$1.40M |
| DMI | 2023-02-15 | 2023-02-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $83.49 | -30.8K | 65.3K | -32% | -$2.57M |
| DI | 2023-02-15 | 2023-02-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +30.8K | 82.7K | +59% | +$1.40M |
| DM | 2022-12-19 | 2022-12-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $71.79 | -29.6K | 85.9K | -26% | -$2.13M |
| D | 2022-12-19 | 2022-12-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | — | +17.2K | 149.0K | +13% | — |
| D | 2022-12-19 | 2022-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | A - Grant | $0.00 | +54.5K | 140.4K | +64% | $0 |
| DI | 2022-08-17 | 2022-08-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +16.7K | 38.4K | +77% | +$717.3K |
| DI | 2022-08-17 | 2022-08-16 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $80.00 | -16.7K | 21.7K | -43% | -$1.34M |
| DMI | 2022-01-12 | 2022-01-11 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $93.10 | -34.6K | 21.7K | -61% | -$3.22M |
| DI | 2022-01-12 | 2022-01-11 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +29.5K | 51.2K | +135% | +$1.27M |
| 2021-12-20 | 2021-12-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $92.00 | -5,082 | 107.6K | -5% | -$467.5K | |
| MI | 2021-12-20 | 2021-12-17 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale | $91.35 | -5,357 | 30.3K | -15% | -$489.3K |
| DMI | 2021-12-16 | 2021-12-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $90.75 | -35.1K | 35.5K | -50% | -$3.19M |
| DM | 2021-12-16 | 2021-12-15+ | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | F - Tax | $90.96 | -16.1K | 84.5K | -16% | -$1.47M |
| DI | 2021-12-16 | 2021-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +29.5K | 56.9K | +107% | +$1.27M |
| D | 2021-12-16 | 2021-12-15 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | A - Grant | $0.00 | +44.0K | 128.5K | +52% | $0 |
| I | 2021-11-23 | 2021-11-23 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | G - Gift | $0.00 | -16.5K | 16.3K | -50% | $0 |
| DMI | 2021-11-22 | 2021-11-18 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $89.79 | -29.5K | 52.7K | -36% | -$2.64M |
| DI | 2021-11-22 | 2021-11-18 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +29.5K | 62.4K | +90% | +$1.27M |
| DMI | 2021-10-13 | 2021-10-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $87.53 | -29.5K | 32.9K | -47% | -$2.58M |
| DMI | 2021-10-13 | 2021-10-12 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $40.16 | +29.5K | 47.6K | +162% | +$1.18M |
| DI | 2021-09-16 | 2021-09-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $37.35 | +29.5K | 62.4K | +90% | +$1.10M |
| DMI | 2021-09-16 | 2021-09-14 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $94.87 | -29.5K | 52.5K | -36% | -$2.79M |
| DMI | 2021-08-11 | 2021-08-10 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $96.42 | -29.5K | 32.9K | -47% | -$2.84M |
| DI | 2021-08-11 | 2021-08-10 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $37.35 | +29.5K | 62.4K | +90% | +$1.10M |
| DMI | 2021-07-15 | 2021-07-13 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $99.37 | -29.5K | 32.9K | -47% | -$2.93M |
| DI | 2021-07-15 | 2021-07-13 | DLB | Dolby Laboratories, Inc. | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $37.35 | +29.5K | 62.4K | +90% | +$1.10M |
Purchase Sale Sale after option exercise All abbreviations